Eur Rev Med Pharmacol Sci 2021; 25 (20): 6245-6259DOI: 10.26355/eurrev_202110_26994 Comparison between use of direct oral anticoagulants and aspirin for risk of thromboembolism complications in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis J.-Y. Cai, C.-M. Cui, J.-K. Min, Y.-Q. Cao, L.-Y. Zhang Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (13): 4499-4505DOI: 10.26355/eurrev_202107_26241 Selecting the right anticoagulant for stroke prevention in atrial fibrillation N.R. Kundnani, C.I. Rosca, A. Sharma, A. Tudor, M.S. Rosca, D.D. Nisulescu, H.S. Branea, V. Mocanu, D.C. Crisan, D.R. Buzas, S. Morariu, D.F. Lighezan Free PDF Download
Eur Rev Med Pharmacol Sci 2018; 22 (15): 5042-5046DOI: 10.26355/eurrev_201808_15647 Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®) S. Hu, G. Belcaro, M. Dugall, P. Peterzan, M. Hosoi, A. Ledda, A. Riva, L. Giacomelli, S. Togni, R. Eggenhoffner4, R. Cotellese Free PDF Download
Eur Rev Med Pharmacol Sci 2015; 19 (20): 3961-3967 Efficacy and safety of dabigatran in a “real-life” population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry V. Russo, V. Bianchi, C. Cavallaro, F. Vecchione, S. De Vivo, L. Santangelo, B. Sarubbi, P. Calabrò, G. Nigro, A. D’Onofrio Free PDF Download
Eur Rev Med Pharmacol Sci 2015; 19 (5): 897-903 Dabigatran etexilate and LMWH for the prevention of venous thromboembolism in 532 patients undergoing hip surgery S. Bonarelli, M.R. Bacchin, I. Frugiuele, M.A. Feoli, F. Facchini, V. Altimari Free PDF Download
Eur Rev Med Pharmacol Sci 2014; 18 (18): 2595- Adverse skin reaction caused by dabigatran M.A. Cakmak, S. Sahin, N. Cinar, S. Karsidag Free PDF Download
Eur Rev Med Pharmacol Sci 2013; 17 (23): 3123-3131 Deep vein thrombosis and novel oral anticoagulants: a clinical review K.M. Burgazli, N. Atmaca, M. Mericliler, M. Parahuleva, A. Erdogan, S.H. Daebritz Free PDF Download